Dr. Bell has built the infrastructure to make state-of-the-art immunotherapies a reality for patients.
The Canadian Cancer Research Alliance (CCRA) announced today that Dr. John Bell is receiving the Outstanding Achievements in Cancer Research Award for his “pioneering work and ground-breaking scientific discoveries, which have propelled the entire field of oncolytic virus therapy forward, and his commitment to enabling translational research.”
Dr. Bell is a professor in the Department of Medicine at the University of Ottawa Faculty of Medicine, and a senior scientist in cancer therapeutics at The Ottawa Hospital. He is a global pioneer in the discovery and development of oncolytic viruses, a novel class of targeted cancer therapeutics.
